Susan Millard
Mater Research Insitute - University of Queensland, Translational Research Institute, QLD, Australia
- This delegate is presenting an abstract at this event.

Dr Millard is a member of the Bone and Immunology Research Group at Mater Research Institute-The University of Queensland (UQ). She completed a PhD in 2006 at University of Adelaide and subsequently undertook postdoctoral research in at UCSF before returning to Australia. Her interests have focused on the dynamic environment of bone and bone marrow. These interests have been furthered through the use of transgenic approaches to understand the influence of cellular signaling pathways in osteoblasts, investigations into cell therapies for treatment of bone disease, and a more recent emphasis on understanding myeloid cell contributions to bone regeneration, bone diseases, and hematopoietic stem cell transplantation.
Presentations this author is a contributor to:
CD169+Mac-2+ osteomacs promote bone regeneration via intramembranous and endochondral ossification (#61)
5:12 PM
Lena Batoon
New Investigator session
CCR2 signalling is not critical in a tibial injury that heals through intramembranous bone healing (#137)
12:30 PM
Lena Batoon
Poster Viewing I (odd numbers)
TNF alpha: a mediator of neurological heterotopic ossification (#121)
5:00 PM
Hsu-Wen Tseng
Welcome Reception & ANZBMS Plenary Posters
Granulocyte-colony stimulating factor treatment reduced prostate cancer associated osteoblastic lesion formation (#221)
12:30 PM
Andy C Wu
Poster Viewing I (odd numbers)
Loss of CD169 alters macrophage populations with subsequent effects on bone anabolism (#180)
12:30 PM
Susan Millard
Poster Viewing II (even numbers)